MONTANOVA CAPITAL, LLC - 23 Dec 2025 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: BNTC
Reported as of: 23 Dec 2025
Net transaction value: +$1,903,133
SEC form: 4
Accepted by SEC: 29 Dec 2025, 19:31:28 UTC
Prior SEC filing: 22 Dec 2025
Next SEC filing: 09 Feb 2026
Source filing: View source filing
Reporting owner signature: Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer

Key filing fact

MONTANOVA CAPITAL, LLC filed Form 4 for Benitec Biopharma Inc. (BNTC) on 29 Dec 2025.

Key facts

This page summarizes MONTANOVA CAPITAL, LLC's Form 4 filing for Benitec Biopharma Inc. (BNTC).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 29 Dec 2025, 19:31.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: +$1,903,133.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (4)

CIK 0001569064 Primary reporting owner

SUVRETTA CAPITAL MANAGEMENT, LLC

Relationship: Director, 10%+ Owner
Address: 540 MADISON AVENUE, 7TH FLOOR, NEW YORK
Signature: Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer
Signature date: 29 Dec 2025

CIK 0001869640

Cowen Aaron

Relationship: 10%+ Owner
Address: C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK
Signature: Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer
Signature date: 29 Dec 2025

CIK 0001939329

Averill Master Fund, Ltd.

Relationship: Director, 10%+ Owner
Address: C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK
Signature: Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer
Signature date: 29 Dec 2025

CIK 0002021243

Averill Madison Master Fund, Ltd.

Relationship: Director, 10%+ Owner
Address: C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK
Signature: Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer
Signature date: 29 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $547,410
Shares: +42,600
Change %: +0.44%
Price: $12.85
Shares after: 9,620,075
Date: 23 Dec 2025
Ownership: See footnotes
Footnotes: F1, F2

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $95,090
Shares: +7,400
Change %: +0.41%
Price: $12.85
Shares after: 1,834,053
Date: 23 Dec 2025
Ownership: See footnotes
Footnotes: F1, F3

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $187,592
Shares: +14,320
Change %: +0.15%
Price: $13.10
Shares after: 9,634,395
Date: 26 Dec 2025
Ownership: See footnotes
Footnotes: F1, F4

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $32,960
Shares: +2,516
Change %: +0.14%
Price: $13.10
Shares after: 1,836,569
Date: 26 Dec 2025
Ownership: See footnotes
Footnotes: F1, F5

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $884,352
Shares: +65,800
Change %: +0.68%
Price: $13.44
Shares after: 9,700,195
Date: 29 Dec 2025
Ownership: See footnotes
Footnotes: F1, F6

BNTC transaction

Common stock, par value $0.0001 per share

Purchase

Transaction value: $155,729
Shares: +11,587
Change %: +0.63%
Price: $13.44
Shares after: 1,848,156
Date: 29 Dec 2025
Ownership: See footnotes
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes